These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10216419)

  • 21. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The precautionary principle: advantages and risks].
    Tubiana M
    J Chir (Paris); 2001 Apr; 138(2):68-80. PubMed ID: 11319454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Net efficacy adjusted for risk: further developments.
    Boada J; Boada C; Garcia MM; Rodriguez C; Garcia M; Fernandez E
    Expert Opin Drug Saf; 2009 Nov; 8(6):649-54. PubMed ID: 19708816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VNS Therapy versus the latest antiepileptic drug.
    Ben-Menachem E; French JA
    Epileptic Disord; 2005 Sep; 7 Suppl 1():S22-6. PubMed ID: 16120490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiattribute model for evaluating the benefit-risk profiles of treatment alternatives.
    Felli JC; Noel RA; Cavazzoni PA
    Med Decis Making; 2009; 29(1):104-15. PubMed ID: 18812582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patients in pre-dialysis: decision taking and free choice of treatment].
    Sarrias Lorenz X; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():119-22. PubMed ID: 19018749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic aspects of risk-benefit analysis.
    Beckmann J
    Semin Thromb Hemost; 1999; 25(1):89-95. PubMed ID: 10327227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of valid measurements of benefit and risk.
    Spitzer WO
    Med Toxicol; 1986; 1 Suppl 1():74-8. PubMed ID: 3821430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concepts in risk-benefit assessment. A simple merit analysis of a medicine?
    Edwards R; Wiholm BE; Martinez C
    Drug Saf; 1996 Jul; 15(1):1-7. PubMed ID: 8862960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A symposium on drugs and adverse effects. Serious problems--but the debate needs balance].
    Lennholm B
    Lakartidningen; 1996 Dec; 93(50):4653-4, 4657. PubMed ID: 8999263
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy monitored by way of following blood concentrations of drugs and its use in limiting therapeutic risks].
    Wierzchowiecki M; Ochotny R
    Przegl Lek; 1979; 36(2):296-9. PubMed ID: 451256
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence in context: one person's poison is another's acceptable risk.
    Haynes RB; Hart L
    Evid Based Med; 2009 Feb; 14(1):5. PubMed ID: 19181938
    [No Abstract]   [Full Text] [Related]  

  • 39. [Simplicity of the therapeutic program as therapeutic principle].
    Hoff F
    Munch Med Wochenschr; 1966 Sep; 108(35):1685-90. PubMed ID: 6014955
    [No Abstract]   [Full Text] [Related]  

  • 40. How to take useful drugs without hurting yourself.
    Lundberg GD
    MedGenMed; 2005 Mar; 7(1):53. PubMed ID: 16369358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.